HENDERSON MICHAEL THOMAS
Insider CIK 1779990 · SYRE Director · BBIO See Remarks · ARYD Director · APGE Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APGE Apogee Therapeutics, Inc. | D To issuer deriv | 2026-09-03 | 2026-09-03 | 387,012 | — | $0 | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer deriv | 2026-09-03 | 2026-09-03 | 253,016 | — | $0 | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer deriv | 2026-09-03 | 2026-09-03 | 357,036 | — | $0 | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer | 2026-09-03 | 2026-09-03 | 920,941 | — | $0 | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer deriv | 2026-09-03 | 2026-09-03 | 253,016 | — | — | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer deriv | 2026-09-03 | 2026-09-03 | 357,036 | — | — | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer deriv | 2026-09-03 | 2026-09-03 | 387,012 | — | — | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer | 2026-09-03 | 2026-09-03 | 920,941 | — | — | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | G Gift | 2026-07-10 | 2026-07-10 | 75,046 | — | $0 | 920,941 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-07-08 | 2026-07-10 | 20,000 | $133.63 | $2.67M | 995,987 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-23 | 20,000 | $100.00 | $2.00M | 68,606 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-24 | 80,000 | $132.54 | $10.60M | 1,015,987 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-06-10 | 2026-06-12 | 614 | $86.89 | $53.4K | 1,095,987 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-06-10 | 2026-06-12 | 2,305 | $86.27 | $198.9K | 1,096,601 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-06-10 | 2026-06-12 | 1,577 | $85.19 | $134.3K | 1,098,906 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-06-10 | 2026-06-12 | 6,770 | $82.21 | $556.6K | 1,109,217 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-06-10 | 2026-06-12 | 1,080 | $84.18 | $90.9K | 1,100,483 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-06-10 | 2026-06-12 | 7,654 | $82.78 | $633.6K | 1,101,563 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | A Award deriv | 2026-05-27 | 2026-05-29 | 8,026 | — | $0 | 8,026 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-05-13 | 2026-05-15 | 1,341 | $82.58 | $110.7K | 1,115,987 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-05-13 | 2026-05-15 | 18,659 | $82.05 | $1.53M | 1,117,328 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-05-08 | 2026-05-08 | 33,513 | $73.72 | $2.47M | 132,689 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-05-08 | 2026-05-08 | 19,269 | $75.35 | $1.45M | 88,606 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-05-08 | 2026-05-08 | 24,814 | $74.76 | $1.86M | 107,875 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-05-08 | 2026-05-08 | 2,404 | $72.57 | $174.5K | 166,202 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise deriv | 2026-04-16 | 2026-04-20 | 3,000 | — | $0 | 387,012 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise | 2026-04-16 | 2026-04-20 | 3,000 | $22.86 | $68.6K | 1,135,987 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-04-08 | 2026-04-10 | 17,800 | $82.48 | $1.47M | 1,135,187 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-04-08 | 2026-04-10 | 200 | $85.00 | $17.0K | 1,132,987 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-04-08 | 2026-04-10 | 2,000 | $83.26 | $166.5K | 1,133,187 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-03-11 | 2026-03-13 | 8,363 | $74.29 | $621.3K | 1,164,624 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-03-11 | 2026-03-13 | 8,219 | $74.83 | $615.0K | 1,156,405 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-03-11 | 2026-03-13 | 3,418 | $75.86 | $259.3K | 1,152,987 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-02-11 | 2026-02-13 | 7,551 | $63.73 | $481.2K | 1,173,942 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-02-11 | 2026-02-13 | 955 | $64.99 | $62.1K | 1,172,987 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-02-11 | 2026-02-13 | 11,494 | $62.96 | $723.7K | 1,181,493 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | J Other | 2026-01-21 | 2026-01-23 | 63,227 | — | $0 | 168,606 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-01-14 | 2026-01-16 | 5,386 | $83.16 | $447.9K | 1,193,457 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-01-14 | 2026-01-16 | 1,440 | $78.64 | $113.2K | 1,211,547 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-01-14 | 2026-01-16 | 470 | $83.79 | $39.4K | 1,192,987 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-01-14 | 2026-01-16 | 1,854 | $82.41 | $152.8K | 1,198,843 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-01-14 | 2026-01-16 | 2,374 | $81.00 | $192.3K | 1,200,697 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-01-14 | 2026-01-16 | 8,476 | $79.82 | $676.6K | 1,203,071 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 253,016 | — | $0 | 253,016 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-12-10 | 2025-12-12 | 560 | $76.58 | $42.9K | 1,212,987 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-12-10 | 2025-12-12 | 10,005 | $75.79 | $758.3K | 1,213,547 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-12-10 | 2025-12-12 | 9,435 | $74.88 | $706.5K | 1,223,552 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-12-04 | 2025-12-05 | 40,000 | $75.01 | $3.00M | 1,232,987 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-11-13 | 2025-11-13 | 100 | $64.52 | $6.5K | 1,272,987 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-11-13 | 2025-11-13 | 1,786 | $63.89 | $114.1K | 1,273,087 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-11-13 | 2025-11-13 | 14,774 | $63.14 | $932.8K | 1,274,873 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-11-13 | 2025-11-13 | 3,340 | $61.93 | $206.8K | 1,289,647 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | A Award deriv | 2025-05-29 | 2025-06-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-03-05 | 2025-03-07 | 7,326 | $29.98 | $219.6K | 1,295,661 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-03-05 | 2025-03-07 | 2,674 | $30.62 | $81.9K | 1,292,987 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-02-05 | 2025-02-07 | 15,000 | $40.58 | $608.7K | 1,302,987 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise deriv | 2025-01-31 | 2025-01-31 | 8,500 | — | $0 | 390,012 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise | 2025-01-31 | 2025-01-31 | 8,500 | $22.86 | $194.3K | 1,317,987 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | J Other | 2025-01-10 | 2025-01-14 | 105,379 | — | $0 | 105,379 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-01-08 | 2025-01-10 | 2,868 | $49.38 | $141.6K | 1,309,487 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-01-08 | 2025-01-10 | 12,132 | $48.72 | $591.1K | 1,312,355 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | A Award deriv | 2024-12-09 | 2024-12-11 | 357,036 | — | $0 | 357,036 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-12-04 | 2024-12-06 | 13,328 | $46.50 | $619.8K | 1,326,159 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-12-04 | 2024-12-06 | 1,672 | $47.19 | $78.9K | 1,324,487 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-11-06 | 2024-11-08 | 1,000 | $59.94 | $59.9K | 1,339,487 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-11-06 | 2024-11-08 | 14,000 | $59.17 | $828.4K | 1,340,487 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-10-02 | 2024-10-04 | 9,712 | $56.74 | $551.1K | 1,354,487 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-10-02 | 2024-10-04 | 30,288 | $56.07 | $1.70M | 1,364,199 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-09-04 | 2024-09-06 | 14,359 | $48.23 | $692.5K | 1,394,487 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-09-04 | 2024-09-06 | 25,641 | $47.28 | $1.21M | 1,408,846 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-08-07 | 2024-08-09 | 32,233 | $40.40 | $1.30M | 1,442,254 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-08-07 | 2024-08-09 | 7,667 | $41.52 | $318.3K | 1,434,587 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-08-07 | 2024-08-09 | 100 | $42.17 | $4.2K | 1,434,487 | SEC↗ |
| ARYD ARYA Sciences Acquisition | D To issuer deriv | 2024-07-31 | 2024-07-31 | 30,000 | — | $0 | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-07-05 | 2024-07-05 | 15,000 | $37.26 | $558.9K | 1,474,487 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | A Award deriv | 2024-05-14 | 2024-05-16 | 11,323 | — | $0 | 11,323 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | A Award deriv | 2023-12-18 | 2023-12-20 | 398,512 | — | $0 | 398,512 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-12-15 | 2020-12-17 | 2,199 | — | $0 | 2,199 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-12-15 | 2020-12-17 | 4,456 | — | $0 | 4,456 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-12-15 | 2020-12-17 | 3,137 | — | $0 | 3,137 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2020-12-01 | 2020-12-02 | 10,000 | — | $0 | 8,282 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-12-01 | 2020-12-02 | 6,972 | $51.69 | $360.4K | 274,211 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2020-12-01 | 2020-12-02 | 10,000 | $1.05 | $10.5K | 284,211 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-12-01 | 2020-12-02 | 3,028 | $51.12 | $154.8K | 281,183 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2020-11-16 | 2020-11-18 | 12,813 | — | $0 | 179,375 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2020-11-16 | 2020-11-18 | 10,000 | — | $0 | 18,282 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-11-16 | 2020-11-18 | 10,000 | $45.00 | $450.0K | 267,751 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2020-11-16 | 2020-11-18 | 6,353 | $44.33 | $281.6K | 274,211 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2020-11-16 | 2020-11-18 | 12,813 | — | $0 | 280,564 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2020-11-16 | 2020-11-18 | 10,000 | $1.05 | $10.5K | 277,751 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2020-11-02 | 2020-11-03 | 10,000 | — | $0 | 28,282 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-11-02 | 2020-11-03 | 500 | $38.92 | $19.5K | 267,751 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2020-11-02 | 2020-11-03 | 10,000 | $1.05 | $10.5K | 277,751 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-11-02 | 2020-11-03 | 9,500 | $38.33 | $364.1K | 268,251 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2020-10-01 | 2020-10-05 | 1,019 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2020-10-01 | 2020-10-05 | 6,745 | — | $0 | 38,282 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2020-10-01 | 2020-10-05 | 2,236 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-10-01 | 2020-10-05 | 5,505 | $39.28 | $216.2K | 267,751 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2020-10-01 | 2020-10-05 | 3,255 | $0.28 | $911 | 271,006 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2020-10-01 | 2020-10-05 | 6,745 | $1.05 | $7.1K | 277,751 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-10-01 | 2020-10-05 | 4,495 | $38.29 | $172.1K | 273,256 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2020-09-18 | 2020-09-22 | 4,901 | — | $0 | 4,586 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2020-09-18 | 2020-09-22 | 5,099 | — | $0 | 2,236 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2020-09-18 | 2020-09-22 | 4,901 | $0.16 | $784 | 272,652 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2020-09-18 | 2020-09-22 | 5,099 | $0.28 | $1.4K | 277,751 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-09-18 | 2020-09-22 | 10,000 | $40.00 | $400.0K | 267,751 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2020-09-01 | 2020-09-03 | 10,000 | — | $0 | 9,487 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-09-01 | 2020-09-03 | 4,978 | $29.58 | $147.2K | 267,751 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2020-09-01 | 2020-09-03 | 10,000 | $0.16 | $1.6K | 277,751 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-09-01 | 2020-09-03 | 5,022 | $27.89 | $140.1K | 272,729 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2020-08-16 | 2020-08-18 | 12,812 | — | $0 | 192,188 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2020-08-16 | 2020-08-18 | 5,460 | $28.53 | $155.8K | 267,751 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2020-08-16 | 2020-08-18 | 12,812 | — | $0 | 273,211 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2020-08-03 | 2020-08-05 | 10,000 | — | $0 | 19,487 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-08-03 | 2020-08-05 | 1,103 | $28.11 | $31.0K | 260,293 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-08-03 | 2020-08-05 | 8,897 | $27.28 | $242.7K | 261,396 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2020-08-03 | 2020-08-05 | 10,000 | $0.16 | $1.6K | 270,293 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2020-07-01 | 2020-07-06 | 10,000 | — | $0 | 29,487 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-07-01 | 2020-07-06 | 200 | $32.67 | $6.5K | 260,293 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2020-07-01 | 2020-07-06 | 10,000 | $0.16 | $1.6K | 270,293 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-07-01 | 2020-07-06 | 7,168 | $30.63 | $219.6K | 263,125 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-07-01 | 2020-07-06 | 2,632 | $31.77 | $83.6K | 260,493 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-06-08 | 2020-06-10 | 506 | $30.00 | $15.2K | 260,393 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-06-08 | 2020-06-10 | 100 | $30.05 | $3.0K | 260,293 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-06-03 | 2020-12-02 | 784 | $30.04 | $23.6K | 261,399 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-06-01 | 2020-06-03 | 2,085 | $29.26 | $61.0K | 262,183 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-06-01 | 2020-06-03 | 500 | $29.79 | $14.9K | 261,683 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2020-05-26 | 2020-05-27 | 18,365 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2020-05-26 | 2020-05-27 | 18,365 | $1.05 | $19.3K | 264,268 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-05-19 | 2020-05-21 | 19,271 | — | $0 | 19,271 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-05-19 | 2020-05-21 | 45,027 | — | $0 | 45,027 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-05-19 | 2020-05-21 | 13,932 | — | $0 | 13,932 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-05-19 | 2020-05-21 | 3,351 | — | $0 | 3,351 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-05-19 | 2020-05-21 | 7,778 | — | $0 | 7,778 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-05-19 | 2020-05-21 | 18,365 | — | $0 | 18,365 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-05-19 | 2020-05-21 | 39,487 | — | $0 | 39,487 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-05-19 | 2020-05-21 | 205,000 | — | $0 | 205,000 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-05-19 | 2020-05-21 | 7,335 | — | $0 | 7,335 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-05-19 | 2020-05-21 | 1,019 | — | $0 | 1,019 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award | 2020-05-19 | 2020-05-21 | 83,541 | — | $0 | 245,903 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-05-05 | 2020-05-06 | 1,460 | $30.47 | $44.5K | 162,362 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-05-04 | 2020-05-05 | 1,320 | $30.01 | $39.6K | 163,822 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-05-01 | 2020-05-05 | 300 | $29.87 | $9.0K | 165,142 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-05-01 | 2020-05-05 | 2,285 | $29.19 | $66.7K | 165,442 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-04-01 | 2020-04-03 | 44 | $25.40 | $1.1K | 170,268 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-04-01 | 2020-04-03 | 1,441 | $26.51 | $38.2K | 168,827 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-04-01 | 2020-04-03 | 1,100 | $27.56 | $30.3K | 167,727 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-03-02 | 2020-03-04 | 1,400 | $32.89 | $46.0K | 170,312 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-03-02 | 2020-03-04 | 2,575 | $32.20 | $82.9K | 171,712 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-02-03 | 2020-02-05 | 3,975 | $34.90 | $138.7K | 174,287 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-01-03 | 2020-01-06 | 26 | $33.00 | $858 | 178,262 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-01-03 | 2020-01-06 | 332 | $32.28 | $10.7K | 178,288 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-01-02 | 2020-01-06 | 1,500 | $32.69 | $49.0K | 180,737 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-01-02 | 2020-01-06 | 115 | $34.45 | $4.0K | 178,620 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-01-02 | 2020-01-06 | 2,002 | $33.61 | $67.3K | 178,735 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2019-07-01 | 2019-07-03 | 5,364 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2019-07-01 | 2019-07-03 | 151,563 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2019-07-01 | 2019-07-03 | 8,420 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2019-07-01 | 2019-07-03 | 8,420 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | P Buy | 2019-07-01 | 2019-07-03 | 7,000 | $17.00 | $119.0K | 180,767 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2019-07-01 | 2019-07-03 | 5,364 | — | $0 | 173,767 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2019-07-01 | 2019-07-03 | 151,563 | — | $0 | 168,403 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2019-07-01 | 2019-07-03 | 8,420 | — | $0 | 16,840 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2019-07-01 | 2019-07-03 | 8,420 | — | $0 | 8,420 | SEC↗ |